Answers are grounded in this paper and cite their sources.
Although allogeneic stem cell transplantation can cure patients with hematologic malignancies, limiting factors such as lack of suitable donors and GVHD toxicity have led to the exploration of umbilical cord blood (UCB) as an alternative source of hematopoietic stem cells. This overview examines the advantages and disadvantages of UCB as a donor source and reviews data from preclinical and clinical studies. Ethical issues regarding UCB transplantation are also addressed.
No takes yet. Share an insight, caveat, or question.
Wadlow et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: